PA
WST icon

Profund Advisors’s West Pharmaceutical WST Stock Holding History

Profund Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Sell
804
-366
-31% -$91.1K 0.01% 1027
2025
Q4 		$322K Buy
1,170
+242
+26% +$66.2K 0.01% 819
2025
Q3 		$243K Buy
928
+12
+1% +$2.92K 0.01% 867
2025
Q2 		$200K Sell
916
-77
-8% -$16.5K 0.01% 908
2025
Q1 		$222K Sell
993
-25
-2% -$6.89K 0.01% 848
2024
Q4 		$333K Sell
1,018
-87
-8% -$27.4K 0.01% 709
2024
Q3 		$332K Sell
1,105
-75
-6% -$23K 0.01% 740
2024
Q2 		$389K Sell
1,180
-25
-2% -$8.84K 0.01% 584
2024
Q1 		$477K Buy
1,205
+79
+7% +$29.2K 0.02% 592
2023
Q4 		$396K Sell
1,126
-8
-0.7% -$2.83K 0.02% 638
2023
Q3 		$425K Sell
1,134
-10
-0.9% -$3.87K 0.02% 506
2023
Q2 		$438K Buy
1,144
+32
+3% +$11.4K 0.02% 553
2023
Q1 		$385K Sell
1,112
-7,675
-87% -$2.24M 0.02% 608
2022
Q4 		$2.07M Buy
8,787
+261
+3% +$61.8K 0.13% 145
2022
Q3 		$2.1M Sell
8,526
-364
-4% -$111K 0.15% 127
2022
Q2 		$2.69M Sell
8,890
-942
-10% -$307K 0.17% 113
2022
Q1 		$4.04M Sell
9,832
-1,073
-10% -$420K 0.17% 96
2021
Q4 		$5.12M Buy
10,905
+9,336
+595% +$4.02M 0.17% 105
2021
Q3 		$666K Buy
1,569
+43
+3% +$18.1K 0.02% 499
2021
Q2 		$549K Buy
1,526
+11
+0.7% +$3.63K 0.02% 613
2021
Q1 		$427K Sell
1,515
-214
-12% -$61.2K 0.02% 700
2020
Q4 		$490K Sell
1,729
-28
-2% -$7.86K 0.02% 547
2020
Q3 		$483K Sell
1,757
-442
-20% -$117K 0.02% 469
2020
Q2 		$500K Sell
2,199
-1,282
-37% -$252K 0.03% 403
2020
Q1 		$530K Sell
3,481
-2,559
-42% -$394K 0.04% 346
2019
Q4 		$908K Sell
6,040
-53
-0.9% -$7.72K 0.04% 379
2019
Q3 		$864K Sell
6,093
-1,852
-23% -$255K 0.04% 368
2019
Q2 		$994K Sell
7,945
-892
-10% -$105K 0.05% 370
2019
Q1 		$974K Buy
8,837
+2,609
+42% +$271K 0.05% 347
2018
Q4 		$611K Sell
6,228
-3,033
-33% -$329K 0.04% 397
2018
Q3 		$1.14M Sell
9,261
-524
-5% -$58.8K 0.04% 350
2018
Q2 		$972K Sell
9,785
-322
-3% -$29.6K 0.04% 388
2018
Q1 		$892K Buy
10,107
+1,151
+13% +$108K 0.04% 477
2017
Q4 		$884K Sell
8,956
-1,233
-12% -$121K 0.03% 510
2017
Q3 		$981K Buy
10,189
+1,030
+11% +$93.2K 0.04% 422
2017
Q2 		$866K Sell
9,159
-2,328
-20% -$214K 0.04% 456
2017
Q1 		$937K Buy
11,487
+718
+7% +$60K 0.04% 479
2016
Q4 		$914K Buy
10,769
+11
+0.1% +$865 0.04% 487
2016
Q3 		$801K Sell
10,758
-833
-7% -$66.1K 0.04% 488
2016
Q2 		$880K Sell
11,591
-1,172
-9% -$85.3K 0.04% 443
2016
Q1 		$885K Sell
12,763
-246
-2% -$14.8K 0.05% 402
2015
Q4 		$783K Buy
13,009
+1,897
+17% +$114K 0.04% 462
2015
Q3 		$601K Sell
11,112
-8,759
-44% -$510K 0.03% 463
2015
Q2 		$1.15M Sell
19,871
-2,441
-11% -$136K 0.05% 346
2015
Q1 		$1.34M Buy
22,312
+7,120
+47% +$379K 0.05% 339
2014
Q4 		$809K Buy
15,192
+2,089
+16% +$104K 0.03% 548
2014
Q3 		$586K Sell
13,103
-6,127
-32% -$260K 0.03% 614
2014
Q2 		$811K Sell
19,230
-1,443
-7% -$61.8K 0.04% 595
2014
Q1 		$911K Sell
20,673
-4,511
-18% -$212K 0.04% 515
2013
Q4 		$1.24M Sell
25,184
-3,428
-12% -$160K 0.06% 384
2013
Q3 		$1.18M Buy
28,612
+11,692
+69% +$446K 0.06% 348
2013
Q2 		$594K Buy
+16,920
New +$557K 0.04% 527

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Profund Advisors's WST Position: Q1 2026 in Review

Profund Advisors reduced its West Pharmaceutical (WST) stake by 31% in Q1 2026, selling an estimated $91.1K and leaving 804 shares worth $202K. The position accounts for 0.01% of the portfolio, ranked #1027.

Profund Advisors first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.12M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Profund Advisors held 804 shares of West Pharmaceutical worth $202K as of Q1 2026.
  • Profund Advisors sold 366 West Pharmaceutical shares in Q1 2026, an estimated $91.1K.
  • West Pharmaceutical made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #1027 holding.
  • Profund Advisors first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • Profund Advisors's West Pharmaceutical position peaked at $5.12M in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.